Table 7.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006

Recipients with Pancreas After Kidney (PAK) Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 379 100.0% 1,189 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 5 1.3% 21 1.8%
OKT3 1 0.3% 7 0.6%
Thymoglobulin 210 55.4% 647 54.4%
Zenapax 13 3.4% 150 12.6%
Simulect 7 1.8% 96 8.1%
Campath 128 33.8% 83 7.0%
Rituximab 1 0.3%    
No Induction Drug Reported 75 19.8% 275 23.1%


Source: OPTN/SRTR Data as of May 1, 2007.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.